Suphrex

Suphrex (Sunitinib) is an oral prescription medication used for treating certain types of cancer. It belongs to a class of drugs known as kinase inhibitors, helping to slow or stop cancer cell growth. Suphrex is available as an oral capsule for systemic therapy.

Suphrex is primarily used to treat gastrointestinal stromal tumors (GIST) when other treatments are not effective, as well as advanced renal cell carcinoma (kidney cancer). It may also be prescribed for advanced pancreatic neuroendocrine tumors (pNET) in adults. Suphrex works by blocking signals that promote tumor growth and blood vessel formation in cancer cells.

Suphrex may help reduce tumor size or slow its progression in eligible patients. Some individuals experience improved symptom control related to their condition while taking this medication. Common effects include fatigue, digestive changes, and skin reactions, which vary by person.

Suphrex should be taken exactly as prescribed by a healthcare provider. Patients should report any unusual symptoms, such as severe fatigue, bleeding, or signs of infection, promptly. Regular medical monitoring is recommended during treatment to assess response and manage side effects.

Suphrex may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Grapefruit products should be avoided due to potential interaction risks. Alcohol use and certain supplements may also influence how Suphrex works in the body.